Inducer | Group No. (treatment) | HP | Collagen | MDA |
---|---|---|---|---|
 | I (Normal) | 14.84 ± 1.24 | 110.80 ± 9.22 | 0.83 ± 0.02 |
TAA | II (TAA) | 42.65 ± 3.65a | 318.19 ± 27.2a | 2.15 ± 0.12a |
 | III (TAA+ silymarin) | 17.33 ± 1.97ab | 129.24 ± 14.66ab | 0.99 ± 0.07ab |
 | IV (TAA then Silymarin) | 16.14 ± 1.43b | 122.14 ± 10.70b | 0.87 ± 0.04 b |
S. mansoni | V (S. mansoni infection). | 32.40 ± 2.35a | 241.83 ± 17.50a | 1.39 ± 0.14a |
 | VI (Praziquantel after infection). | 31.72 ± 2.68a | 236.62 ± 20.02a | 1.32 ± 0.05a |
 | VII (Silymarin during infection). | 19.28 ± 1.35ab | 143.84 ± 10.08ab | 1.09 ± 0.07a |
 | VIII (Silymarin after infection). | 21.92 ± 1.54ab | 163.51 ± 11.47ab | 1.14 ± 0.05a |
 | IX (Silymarin after Prazaquantel). | 15.94 ± 1.31b | 118.88 ± 9.76b | 0.85 ± 0.01b |
Ethanol | X (Ethanol). | 37.96 ± 3.20a | 283.19 ± 23.88a | 1.74 ± 0.06a |
 | XI (Silymarin during ethanol intake). | 17.70 ± 1.58ab | 132.04 ± 11.79ab | 0.95 ± 0.02ab |
 | XII (Silymarin after ethanol intake). | 15.98 ± 1.82b | 119.21 ± 13.55b | 0.87 ± 0.03b |